Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
Condition(s):DLBCL – Diffuse Large B Cell LymphomaLast Updated:February 9, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):DLBCL – Diffuse Large B Cell LymphomaLast Updated:February 9, 2024Not yet recruiting
Condition(s):Ewing’s SarcomaLast Updated:January 29, 2020Terminated
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:June 8, 2015Completed
Condition(s):Cardiac Toxicity; LymphomaLast Updated:August 26, 2013Completed
Condition(s):Anthracycline ExtravasationLast Updated:October 21, 2015Completed
Condition(s):Cardiac Toxicity; Inflammatory Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IV Breast CancerLast Updated:January 16, 2013Terminated
Condition(s):Hodgkin Lymphoma in Remission; Leukemia in Remission; Lymphoblastic Lymphoma; Osteosarcoma; Recurrent Leukemia; Recurrent Lymphoma; Recurrent Malignant NeoplasmLast Updated:March 15, 2024Recruiting
Condition(s):Cardiac Toxicity; SarcomaLast Updated:August 5, 2014Completed
Condition(s):Cardiac Toxicity; LymphomaLast Updated:July 24, 2014Completed
Condition(s):Cardiac Toxicity; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:January 17, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.